Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Biomed Khim ; 64(4): 360-367, 2018 Aug.
Article in Russian | MEDLINE | ID: mdl-30135284

ABSTRACT

The effectiveness of three various combinations of an immunomodulator with an antioxidant and a membrane protector in the correction of metabolic and immune disorders has been studied in the experiment under 60-days ethanol intoxication. The development of such biochemical syndromes of the liver damage as cytolysis, intrahepatic, intracellular cholestasis, toxic liver damage by necrotic type, insufficiency of synthetic processes and inflammatory has been revealed. Oxidative stress development and the activation of lipid peroxidation on the systemic (blood plasma) and local level (erythrocytes) have been established. Suppression of adaptive immunity formation and phagocytic capabilities of neutrophils under the increase in their oxygen-dependent activity has been determined, which indicates the presence and possible progression of the inflammatory process at the systemic level. A disorder of erythrocytes metabolic activity, a decrease in stable metabolites of nitric oxide detected in blood plasma been revealed, indicating its uncompensated consumption, causing vasoconstriction and thrombosis, which can additionally arise due to the established increase in the prothrombin index. Combined use of "Longidasa", "Mexicor", "Essentiale forte N" or "Glutoxim", "Mexidol", "Heptral" was more effective in the correction of immune-metabolic disorders in chronic alcohol intoxication than "Hepon", "Hypoxen" and "Phosphogliv".


Subject(s)
Alcoholism/drug therapy , Antioxidants/therapeutic use , Erythrocytes/drug effects , Hypolipidemic Agents/therapeutic use , Immune System/drug effects , Immunologic Factors/therapeutic use , Liver/drug effects , Alcoholism/blood , Alcoholism/immunology , Animals , Antioxidants/administration & dosage , Disease Models, Animal , Drug Therapy, Combination , Erythrocytes/metabolism , Hypolipidemic Agents/administration & dosage , Immunologic Factors/administration & dosage , Lipid Peroxidation/drug effects , Lipid Peroxidation/immunology , Liver/metabolism , Liver Function Tests , Male , Nitric Oxide/blood , Oxidative Stress/drug effects , Oxidative Stress/immunology , Rats, Wistar
2.
Urologiia ; (1): 42-6, 2012.
Article in Russian | MEDLINE | ID: mdl-22646001

ABSTRACT

Patients with chronic prostatitis alone and in combination with prostatic adenoma have changes in the activity of the complement system, neutrophil function and content of pro- and anti-inflammatory cytokines. Abnormal representation of the proteins of the red cell membrane in patients with prostatic diseases affects structural and functional activity of erythrocytes in these patients. Dynamic changes in immune status of patients with chronic prostatitis and prostatic adenoma correlate with changes in functional red cell activity. This fact helps better understanding of pathogenesis of chronic prostatitis and prostatic adenoma.


Subject(s)
Erythrocytes/immunology , Erythrocytes/pathology , Prostatic Diseases/blood , Homeostasis , Humans , Male , Prostatic Diseases/immunology , Prostatic Hyperplasia/blood , Prostatic Hyperplasia/immunology , Prostatic Neoplasms/blood , Prostatic Neoplasms/immunology , Prostatitis/blood , Prostatitis/immunology
3.
Urologiia ; (1): 31-4, 2011.
Article in Russian | MEDLINE | ID: mdl-21500492

ABSTRACT

Patients with prostatic adenoma combined with chronic prostatitis were found to have abnormal content of proteins in peripheral blood erythrocytic membrane, erythrocytic sorption, concentration of nitric oxide stable metabolites, endotheline-1 and lipid peroxidation products in blood plasma before and after transurethral resection of the prostate. Different dosage forms of the drug longidase were tested for efficacy in correction of impairment of structural and functional properties of erythrocytes, endothelial dysfunction and lipid peroxidation in the above patients.


Subject(s)
Endothelium, Vascular/physiopathology , Erythrocytes/physiology , Lipid Peroxidation , Prostatic Hyperplasia/blood , Prostatitis/blood , Endothelin-1/blood , Endothelium, Vascular/drug effects , Erythrocytes/drug effects , Erythrocytes/metabolism , Humans , Hyaluronoglucosaminidase/administration & dosage , Hyaluronoglucosaminidase/therapeutic use , Injections, Intramuscular , Lipid Peroxidation/drug effects , Lipid Peroxides/blood , Male , Membrane Proteins/metabolism , Nitric Oxide/metabolism , Piperazines/administration & dosage , Piperazines/therapeutic use , Polymers/administration & dosage , Polymers/therapeutic use , Postoperative Care/methods , Prostatic Hyperplasia/complications , Prostatic Hyperplasia/physiopathology , Prostatic Hyperplasia/surgery , Prostatitis/complications , Prostatitis/physiopathology , Prostatitis/surgery , Suppositories , Transurethral Resection of Prostate , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...